SCHEMBL6004280

SCHEMBL6004280

CC(Cc1ccc(OCCN2c3ccccc3Oc3ccccc32)cc1)(Oc1ccccc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 20/20 0.57
PPARG P37231 15/20 0.57
PPARD Q03181 9/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7246699 0.89 PPARA (0.58) PPARAPPARGPPARD
SCHEMBL6002497 0.89 PPARA (0.62) PPARAPPARGPPARD
SCHEMBL7246043 0.87 PPARG (0.59) PPARAPPARGPPARD
SCHEMBL6003901 0.85 PPARA (0.52) PPARAPPARGPPARD
SCHEMBL5100830 0.81 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL7252703 0.81 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL7926847 0.80 PPARG (0.62) PPARAPPARGPPARD
SCHEMBL7253863 0.80 PPARG (0.62) PPARAPPARGPPARD
SCHEMBL7246694 0.79 PPARG (0.55) PPARAPPARGPPARD
SCHEMBL7514537 0.77 PPARG (0.74) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002537390-A 2002-11-05 JP claimed
US-6440961-B1 Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION (IN) 2002-08-27 US claimed
US-20020077320-A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION AND REDDY- CHEMINOR, INC. 2002-06-20 US claimed
EP-1155006-A1 NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN MEDICINE; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM Dr. Reddy's Research Foundation (IN) 2001-11-21 EP claimed
CN-1280575-A Novel tricyclic compounds and their use as medicaments, process for their preparation and pharmaceutical compositions containing them REDDY CHEMINOR INC (IN) 2001-01-17 CN claimed
EP-1049684-A1 NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN MEDICINE; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S RESEARCH FOUNDATION (IN) 2000-11-08 EP claimed
WO-2000050414-A1 NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN MEDICINE; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM DR.REDDY'S RESEARCH FOUNDATION (IN) 2000-08-31 WO claimed
WO-1999019313-A1 NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN MEDICINE; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S RESEARCH FOUNDATION (IN) 1999-04-22 WO claimed
US-7119198-B2 Tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION (IN) 2006-10-10 US disclosed
US-20060148793-A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them REDDYS'S RESEARCH FOUNDATION 2006-07-06 US disclosed
US-6939988-B1 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2005-09-06 US disclosed
US-6608194-B1 Hypolipidemic, antihyperglycemic, antiobesity and hypocholes-terolemic agents DR. REDDY'S LABORATORIES LIMITED (IN) 2003-08-19 US disclosed
US-6548666-B1 Phenazine, phenoxazine, or phenothiazine derivatives; antilipemic, hypoglycemic, anticholesterol and antiobesity agents DR. REDDY'S RESEARCH FOUNDATION (IN) 2003-04-15 US disclosed
US-6440961-B1 Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION (IN) 2002-08-27 US disclosed
US-20020077320-A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION AND REDDY- CHEMINOR, INC. 2002-06-20 US disclosed
EP-1155006-A1 NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN MEDICINE; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM Dr. Reddy's Research Foundation (IN) 2001-11-21 EP disclosed
EP-1049684-A1 NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN MEDICINE; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S RESEARCH FOUNDATION (IN) 2000-11-08 EP disclosed
WO-2000050414-A1 NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN MEDICINE; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM DR.REDDY'S RESEARCH FOUNDATION (IN) 2000-08-31 WO disclosed
US-6054453-A HYPOLIPIDEMIC, ANTIHYPERGLYCEMIC USES. REDD'S RESEARCH FOUNDATION (IN) 2000-04-25 US disclosed
WO-1999019313-A1 NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN MEDICINE; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S RESEARCH FOUNDATION (IN) 1999-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020077320-A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them LIPC, GPR119, CPT1A PPARA 281/4885PPARG 102/4885PPARD 308/4885
US-20060148793-A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them LIPC, GPR119, CPT1A PPARA 209/4885PPARG 73/4885PPARD 235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.